ArticleNature cancer2021

Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma.

Shuai Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.